The effects of nitroglycerin during cardiopulmonary resuscitation

Eur J Pharmacol. 2014 Jul 5:734:42-9. doi: 10.1016/j.ejphar.2014.04.002. Epub 2014 Apr 13.

Abstract

The outcome for both in-hospital and out-of hospital cardiac arrest remains dismal. Vasopressors are used to increase coronary perfusion pressure and thus facilitate return of spontaneous circulation during cardiopulmonary resuscitation. However, they are associated with a number of potential adverse effects and may decrease endocardial and cerebral organ blood flow. Nitroglycerin has a favourable haemodynamic profile which promotes forward blood flow. Several studies suggest that combined use of nitroglycerin with vasopressors during resuscitation, is associated with increased rates of resuscitation and improved post-resuscitation outcome. This article reviews the effects of nitroglycerin during cardiopulmonary resuscitation and postresuscitation period, as well as the beneficial outcomes of a combination regimen consisting of a vasopressor and a vasodilator, such as nitroglycerin.

Keywords: Blood flow; Cardiac arrest; Cardiopulmonary resuscitation; Nitroglycerin; Vasopressor.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiopulmonary Resuscitation / methods*
  • Humans
  • Neuroprotective Agents / pharmacology*
  • Nitroglycerin / pharmacology*
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / therapy
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Neuroprotective Agents
  • Vasoconstrictor Agents
  • Nitroglycerin